Expression of Heat Shock Protein 70 Gene and Its Correlation with Inflammatory Markers in Essential Hypertension

Kamna Srivastava1, Rajiv Narang2, Jagriti Bhatia3

  • 1Dr. B R Ambedkar Center for Biomedical Research, University of Delhi, Delhi-110007, India.

Plos One
|March 19, 2016
PubMed

Insights

Elevated Heat Shock Protein 70 (HSP70) gene and protein expression is significantly higher in patients with essential hypertension. This increased HSP70 expression correlates with inflammatory markers, suggesting a role in hypertension.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Immunology

Background:

  • Essential hypertension is a major risk factor for cardiovascular diseases.
  • Elevated inflammatory markers are linked to hypertension, but HSP70's role is unclear.
  • Previous studies show increased levels of TNF-alpha, IL-6, CRP, and p53 in hypertension.

Purpose of the Study:

  • To investigate Heat Shock Protein 70 (HSP70) expression at mRNA and protein levels in essential hypertension patients.
  • To explore the relationship between HSP70 and other inflammatory markers in essential hypertension.

Main Methods:

  • Real-time PCR used to measure HSP70 mRNA levels.
  • Indirect ELISA and Western Blot techniques employed for HSP70 protein quantification.
  • Study included 132 essential hypertension patients and 132 healthy controls.

Main Results:

  • HSP70 gene expression was significantly higher (approx. 6.45 fold) in hypertensive patients versus controls (P < 0.0001).
  • HSP70 protein expression in plasma was also significantly elevated in patients compared to controls (P < 0.0001).

Conclusions:

  • Increased HSP70 expression is positively correlated with inflammatory markers in essential hypertension.
  • This correlation may indicate an important role for HSP70 in the pathogenesis of essential hypertension.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
710
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.2K